Thousand Oaks Biopharmaceuticals
A developer of biopharmaceutical technologies intended to produce protein and vaccine compounds.
Launch date
Employees
Market cap
-
Enterprise valuation
$940m—1.4b (Dealroom.co estimates Dec 2021.)
Shantou Guangdong (HQ)
